One person can make a difference. Nowhere is that more evident than the story of Dr. Gordon “Gordy” Klatt and the American Cancer Society Relay for Life, which started in Tacoma, Washington, as the City of Destiny Classic 24-Hour Run Against Cancer in 1985.
In May 1985, Klatt spent a grueling 24 hours circling the track at Baker Stadium at the University of Puget Sound in Tacoma.
Friends, family and patients watched and supported him as he ran and walked more than 83.6 miles and raised $27,000 through pledges for the fight against cancer. As he circled the track, he thought of how he could get others to take part.
He envisioned having teams participate in a 24-hour event to raise money to fight cancer. In 1986, 19 teams were part of the first relay event at the historical Stadium Bowl, and raised $33,000.
Gordy’s vision has grown into a nationwide event raising nearly $5 billion in fundraising to save lives from cancer. In addition, the American Cancer Society licenses 20 non-governmental cancer organizations in other countries to hold Relay for Life events to battle cancer across the globe.
Klatt passed away on Aug. 3, 2014, at the age of 71 from heart failure after battling stomach cancer.
Gordy was one of a kind. He helped shape an idea that started off as one man running and walking a track, and turned it into a global phenomenon for saving lives in every corner of the world.
As Gordy would still say, “Keep up the fight!”
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less